These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25531851)

  • 21. Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes.
    Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1054-61. PubMed ID: 19101096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity.
    Goerres GW; Schmid DT; Grätz KW; von Schulthess GK; Eyrich GK
    Oral Oncol; 2003 Sep; 39(6):547-51. PubMed ID: 12798396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 18F-FDG PET in squamous cell carcinoma of the oral cavity and oropharynx: a study on inter- and intraobserver agreement.
    Krabbe CA; Pruim J; Scholtens AM; Roodenburg JL; Brouwers AH; Phan TT; Agool A; Dijkstra PU
    J Oral Maxillofac Surg; 2010 Jan; 68(1):21-7. PubMed ID: 20006150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET.
    Olsen JR; Dehdashti F; Siegel BA; Zighelboim I; Grigsby PW; Schwarz JK
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):772-7. PubMed ID: 20888130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
    Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative predictive model of cervical lymph node metastasis combining fluorine-18 fluorodeoxyglucose positron-emission tomography/computerized tomography findings and clinical factors in patients with oral or oropharyngeal squamous cell carcinoma.
    Mochizuki Y; Omura K; Nakamura S; Harada H; Shibuya H; Kurabayashi T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):274-82. PubMed ID: 22668784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of only 18F-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma.
    Lee SH; Huh SH; Jin SM; Rho YS; Yoon DY; Park CH
    Otolaryngol Head Neck Surg; 2012 Oct; 147(4):692-8. PubMed ID: 22535915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occult squamous cell carcinoma of the uvula detected by F-18 FDG PET/CT in a case of carcinoma of unknown primary in the head and neck.
    Salem S; Patel NH; Barwick T; Al-Nahhas A; Howard DJ; Zerizer I; Win Z
    Clin Nucl Med; 2010 Oct; 35(10):800-1. PubMed ID: 20838291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology.
    Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Wang HM; See LC; Chen TM; Kang CJ; Wu YF; Lin KJ; Liao CT
    J Nucl Med; 2005 May; 46(5):775-81. PubMed ID: 15872350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of FDG-PET/CT in staging and follow-up of head and neck squamous cell carcinoma.
    Mak D; Corry J; Lau E; Rischin D; Hicks RJ
    Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):487-99. PubMed ID: 22019706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential for truncating the scan length of restaging FDG-PET/CT after chemoradiotherapy in head and neck squamous cell carcinoma.
    Huang YT; Ravi Kumar AS
    Nucl Med Commun; 2012 May; 33(5):503-8. PubMed ID: 22262244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracapsular spread and FDG PET/CT correlations in oral squamous cell carcinoma.
    Joo YH; Yoo IR; Cho KJ; Park JO; Nam IC; Kim MS
    Int J Oral Maxillofac Surg; 2013 Feb; 42(2):158-63. PubMed ID: 23219708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical usefulness of [18F]FDG PET-CT and CT/MRI for detecting nodal metastasis in patients with hypopharyngeal squamous cell carcinoma.
    Shin NY; Lee JH; Kang WJ; Koh YW; Sohn B; Kim J
    Ann Surg Oncol; 2015 Mar; 22(3):994-9. PubMed ID: 25201502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
    Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
    Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
    J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus.
    Kim JW; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2013 May; 49(5):449-53. PubMed ID: 23321549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast-enhanced ¹⁸F-FDG-PET/CT for the assessment of necrotic lymph node metastases.
    Haerle SK; Strobel K; Ahmad N; Soltermann A; Schmid DT; Stoeckli SJ
    Head Neck; 2011 Mar; 33(3):324-9. PubMed ID: 20652890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.
    Schwartz DL; Ford E; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellyn B; Mattes D; Meyer J; Phillips M; Leblanc M; Kinahan P; Krohn K; Eary J; Laramore GE
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):129-36. PubMed ID: 15629603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term results of positron emission tomography-directed management of the neck in node-positive head and neck cancer after organ preservation therapy.
    Sjövall J; Chua B; Pryor D; Burmeister E; Foote MC; Panizza B; Burmeister BH; Porceddu SV
    Oral Oncol; 2015 Mar; 51(3):260-6. PubMed ID: 25553622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of reconstruction parameters in high-definition PET/CT on assessment of lymph node metastases in head and neck squamous cell carcinoma.
    Sadick M; Molina F; Frey S; Piniol R; Sadick H; Brade J; Fink C; Schoenberg SO; He Y
    J Nucl Med Technol; 2013 Mar; 41(1):19-25. PubMed ID: 23365259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.